SE387951B - Forfarande for framstellning av 17alfa-karboxylat eller neutrala 17alfa-fosfat-eller-karbonatestrar av 17alfa21-dihydroxi-20-oxo-steroider - Google Patents

Forfarande for framstellning av 17alfa-karboxylat eller neutrala 17alfa-fosfat-eller-karbonatestrar av 17alfa21-dihydroxi-20-oxo-steroider

Info

Publication number
SE387951B
SE387951B SE7310985A SE7310985A SE387951B SE 387951 B SE387951 B SE 387951B SE 7310985 A SE7310985 A SE 7310985A SE 7310985 A SE7310985 A SE 7310985A SE 387951 B SE387951 B SE 387951B
Authority
SE
Sweden
Prior art keywords
17alfa
17alfa21
dihydroxi
steroids
carboxylate
Prior art date
Application number
SE7310985A
Other languages
English (en)
Swedish (sv)
Inventor
G H Phillipps
B M Baim
G Durrant
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of SE387951B publication Critical patent/SE387951B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/005Compounds containing elements of Groups 1 or 11 of the Periodic Table without C-Metal linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/08Copper compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Steroid Compounds (AREA)
SE7310985A 1972-08-11 1973-08-10 Forfarande for framstellning av 17alfa-karboxylat eller neutrala 17alfa-fosfat-eller-karbonatestrar av 17alfa21-dihydroxi-20-oxo-steroider SE387951B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3765572A GB1440063A (en) 1972-08-11 1972-08-11 17alpha-esters of 17alpha,21-dihydroxy-20-oxo-steroids

Publications (1)

Publication Number Publication Date
SE387951B true SE387951B (sv) 1976-09-20

Family

ID=10398029

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7310985A SE387951B (sv) 1972-08-11 1973-08-10 Forfarande for framstellning av 17alfa-karboxylat eller neutrala 17alfa-fosfat-eller-karbonatestrar av 17alfa21-dihydroxi-20-oxo-steroider

Country Status (16)

Country Link
US (1) US3891631A (es)
JP (1) JPS5752359B2 (es)
BE (1) BE803461A (es)
CA (1) CA1027109A (es)
CH (1) CH590884A5 (es)
DE (1) DE2340591A1 (es)
DK (1) DK135998B (es)
ES (1) ES417738A1 (es)
FR (1) FR2205508B1 (es)
GB (1) GB1440063A (es)
IE (1) IE38312B1 (es)
IL (1) IL42942A (es)
LU (1) LU68212A1 (es)
NL (1) NL7311072A (es)
SE (1) SE387951B (es)
ZA (2) ZA735452B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1516095A (en) * 1974-07-31 1978-06-28 Glaxo Lab Ltd 17,21-diesters of 17alpha,21-dihydroxy-steroids of the pregnane series
GB1593978A (en) * 1976-12-31 1981-07-22 Lark Spa Anti-inflammatory steroids
US4086254A (en) * 1977-04-13 1978-04-25 The Upjohn Company Photocleavable steroids
DE2735110A1 (de) * 1977-08-04 1979-02-15 Hoechst Ag Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung
DE2759135A1 (de) * 1977-12-30 1979-07-19 Lark Spa Neue steroidverbindungen und deren herstellung und verwendung
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
JPS58161340A (ja) * 1982-03-19 1983-09-24 Hitachi Ltd 製品移送装置
AU558725B2 (en) * 1983-09-07 1987-02-05 Mitsubishi Kasei Corporation Corticoid derivatives
JPH0527014Y2 (es) * 1985-10-31 1993-07-08
DE3637806A1 (de) * 1986-11-06 1988-05-19 Hoechst Ag Verfahren zur herstellung von prednisolon-17-ethylcarbonat durch umlagerung von prednisolon-21-ethylcarbonat
FR2683530B1 (fr) * 1991-11-08 1994-01-21 Roussel Uclaf Nouveau procede de preparation de derives 20-oxo 17 alpha, 21-dihydroxyles du pregnane et nouveaux intermediaires.
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
DK1305329T4 (da) * 2000-08-05 2015-06-15 Glaxo Group Ltd 6alpha, 9alpha-difluor-17alpha-(2-furanylcarboxyl)oxy-11beta-hydroxy-16alpha-methyl-3-oxo-androst-1,4-dien-17-carbothiosyre-S-fluormethylester som et antiinflammatorisk middel
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
PL366937A1 (en) * 2001-04-30 2005-02-07 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
AU2002356759A1 (en) * 2001-12-01 2003-06-17 Glaxo Group Limited 17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
CN103739647B (zh) * 2008-05-28 2017-06-09 雷沃根生物医药有限公司 用于治疗疾病的NF‑κB的非激素甾体调节剂
EP2556083A4 (en) 2010-04-05 2013-12-04 Validus Biopharma Inc NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT
WO2017004205A1 (en) 2015-06-29 2017-01-05 Reveragen Biopharma, Inc. NON-HORMONAL STEROID MODULATORS OF NF-κB FOR TREATMENT OF DISEASE
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3255218A (en) * 1962-03-28 1966-06-07 Schering Corp 17(20)-enol-21-aldehydes of the pregnane series
US3780177A (en) * 1967-06-16 1973-12-18 Warner Lambert Co 17-butyrate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use
IT1034011B (it) * 1969-06-26 1979-09-10 Vister Vismara Terapeutici S P Processo per la prapratzione di 17 monoesteri di 17 a 21 diossisteroidi per idrolisi die corpispondenti 17 21 ortoesteri ciclici a ph control lato

Also Published As

Publication number Publication date
GB1440063A (en) 1976-06-23
DK135998C (es) 1977-12-27
NL7311072A (es) 1974-02-13
AU5914373A (en) 1975-02-13
FR2205508B1 (es) 1978-09-15
JPS4985062A (es) 1974-08-15
IE38312L (en) 1974-02-11
CH590884A5 (es) 1977-08-31
ES417738A1 (es) 1976-06-16
ZA735453B (en) 1974-10-30
DK135998B (da) 1977-07-25
LU68212A1 (es) 1973-10-16
DE2340591A1 (de) 1974-03-07
IE38312B1 (en) 1978-02-15
BE803461A (fr) 1974-02-11
IL42942A0 (en) 1973-11-28
US3891631A (en) 1975-06-24
IL42942A (en) 1977-05-31
JPS5752359B2 (es) 1982-11-06
ZA735452B (en) 1974-07-31
FR2205508A1 (es) 1974-05-31
CA1027109A (en) 1978-02-28

Similar Documents

Publication Publication Date Title
SE387951B (sv) Forfarande for framstellning av 17alfa-karboxylat eller neutrala 17alfa-fosfat-eller-karbonatestrar av 17alfa21-dihydroxi-20-oxo-steroider
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE386445B (sv) Forfaranden for framstellning av nya bensotiadiazoler
AR207429A1 (es) Procedimiento de preparacion de acidos 7-acilamido-3-cefem-4-carboxilicos
SE386892B (sv) Forfarande for framstellning av oxaminoforeningar
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE414025B (sv) Forfarande for framstellning av fototropa flerfokala glasogonglas
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
DK150516C (da) Fremgangsmaade til fremstilling af derivater af cephalosporiner eller penicilliner
SE416176B (sv) Forfarande for framstellning av hogdoserade autibiotikatabletter
SE404525B (sv) Forfarande for framstellning av 4-aminometyl-cyklohexan-karboxylsyra-1
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
SE395897B (sv) Forfarande for framstellning av 7beta-acylamido-3-metyl-cef-3-em-4-karbonsyror
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE393808B (sv) Forfarande for framstellning av isomaltit
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
SE7613610L (sv) Forfarande for framstellning av penicilliner eller cefalosporiner
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
NO138947C (no) Fremgangsmaate ved fremstilling av 2-alkoxy-5-alkylsulfonyl-benzoesyrer
NO140736C (no) Fremgangsmaate til fremstilling av poly-alfa-oksyakrylsyre
NO136750C (no) Fremgangsm}te for fremstilling av indanderivater
SE389862B (sv) Forfarande for framstellning av alfa-6-deoxitetracykliner
SE395005B (sv) Forfarande for framstellning av 1-arylidenamino-4-(2-oxo-3-fenyl-3-bensofuryl)-piperaziner